NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

One thing you might notice is that many of the buyers that are longs are associated with the medical or cancer research profession. We’re not financial gurus, but are betting on the science of this technology driving a very large change in the landscape of cancer care. The financial component of that is well known and based on a greater than 100 billion dollar market for cancer therapy, many of us believe that NWBO has the science to capture a small to significant share of that. Even 2% of it is 2 billion dollars.

I’m not sure that the short argument considers the science thoroughly. Their argument is that management is incompetent and will never be able to get a product through trials to market, despite being very late in P3 with exciting data. Right to try isn’t considered either. Shorts are banking on the product and management to fail completely. The only endgame for them is bankruptcy, as if being a penny stock isn’t enough.

I’m still looking forward to seeing some results and will hold through ASCO. Happy Memorial Day everyone. I’m not ready to count this one out.